Supplement

See all supplements

Hepatitis C

Vol. 474 No. 7350_supp S1-S48

In this Supplement
Infecting around 120 million people worldwide, hepatitis C virus (HCV) is more common than HIV yet it is a neglected epidemic. Diagnosis is hard, treatment is arduous, and there is no vaccine. However, for the first time in decades, new drugs are about to be launched that could substantially improve treatment and herald a new era of HCV awareness.

Cover Art: Nik Spencer

Outlook

Top

Hepatitis C
- Herb Brody
Nature 474, S1 (09 June 2011)
Introduction: A smouldering public-health crisis
- Lauren Gravitz
Nature 474, S2-S4 (09 June 2011)
Therapeutics: New drugs hit the target
- Jana Schlütter
Nature 474, S5-S7 (09 June 2011)
Perspective: Miles to go before we sleep
- Charles Rice
Nature 474, S8 (09 June 2011)
Pharmacogenomics: Playing the odds
- Amy Maxmen
Nature 474, S9-S10 (09 June 2011)
Perspective: Recognizing resistance
- Diana Sylvestre
Nature 474, S11 (09 June 2011)
Global health: A uniquely Egyptian epidemic
- Mohammed Yahia
Nature 474, S12-S13 (09 June 2011)
Research technique: The murine candidate
- Elie Dolgin
Nature 474, S14-S15 (09 June 2011)
Vaccines: A moving target
- Michael Eisenstein
Nature 474, S16-S17 (09 June 2011)
Perspective: Test and treat this silent killer
- Brian R. Edlin
Nature 474, S18-S19 (09 June 2011)
Diagnostics: A testing journey
- Sarah DeWeerdt
Nature 474, S20-S21 (09 June 2011)

Collection

Top

Immune boost for viral hepatitis
- Benoît Callendret
- Christopher Walker
Nature Medicine 17, 252-253 (07 March 2011)
Fighting a defiant virus
- Joshua T Schiffer
- John Scott
- Lawrence Corey
Nature Medicine 17, 253-254 (07 March 2011)
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
- Christopher T Jones
- Maria Teresa Catanese
- Lok Man J Law
- Salman R Khetani
- Andrew J Syder
- Alexander Ploss
- Thomas S Oh
- John W Schoggins
- Margaret R MacDonald
- Sangeeta N Bhatia
- Charles M Rice
Nature Biotechnology 28, 167-171 (31 January 2011)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- David L. Thomas
- Chloe L. Thio
- Maureen P. Martin
- Ying Qi
- Dongliang Ge
- Colm O�hUigin
- Judith Kidd
- Kenneth Kidd
- Salim I. Khakoo
- Graeme Alexander
- James J. Goedert
- Gregory D. Kirk
- Sharyne M. Donfield
- Hugo R. Rosen
- Leslie H. Tobler
- Michael P. Busch
- John G. McHutchison
- David B. Goldstein
- Mary Carrington
Nature 461, 798-801 (08 October 2009)
The dawn of a new era in HCV therapy
- Sandra Ciesek
- Michael P. Manns
Nature Reviews Gastroenterology and Hepatology 8, 69-71 (February 2011)
Enhancing treatment for hepatitis C among drug users
- Jason Grebely
- Gregory J. Dore
Nature Reviews Gastroenterology and Hepatology 8, 11-13 (January 2011)
ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
- Jacques Fellay
- Alexander J.Thompson
- Dongliang Ge
- Curtis E. Gumbs
- Thomas J. Urban
- Kevin V. Shianna
- Latasha D. Little
- Ping Qiu
- Arthur H. Bertelsen
- Mark Watson
- Amelia Warner
- Andrew J. Muir
- Clifford Brass
- Janice Albrecht
- Mark Sulkowski
- John G. McHutchison
- David B. Goldstein
Nature 464, 405-408 (18 March 2010)
Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy
- Magdalena Sarasin-Filipowicz
- Jacek Krol
- Ilona Markiewicz
- Markus H Heim
- Witold Filipowicz
Nature Medicine 15, 31-33 (January 2009)

NatureJobs.com

NatureEvents Directory

QD2018 - International Conference on Quantum Dots

25 June 2018 — 29 June 2018

University of Toronto, St George St, Toronto, Canada
Biopharma Innovation Cup 2018

16 July 2018 — 24 July 2018

Frankfurt, Germany
International Conference on Physics, Mathematics and Statistics（ICPMS 2018）

12 May 2018 — 14 May 2018

Supplement

Hepatitis C

In this Supplement

Outlook

Hepatitis C

Introduction: A smouldering public-health crisis

Therapeutics: New drugs hit the target

Perspective: Miles to go before we sleep

Pharmacogenomics: Playing the odds

Perspective: Recognizing resistance

Global health: A uniquely Egyptian epidemic

Research technique: The murine candidate

Vaccines: A moving target

Perspective: Test and treat this silent killer

Diagnostics: A testing journey

Collection

Immune boost for viral hepatitis

Fighting a defiant virus

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

The dawn of a new era in HCV therapy

Enhancing treatment for hepatitis C among drug users

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

Science jobs

NatureJobs.com

Principal Investigator at IDG / McGovern Institute for Brain Research at Peking University

Top Job Openings: School of Pharmaceutical Sciences (Shenzhen)

Recruitment of Faculty and Staff for the Center for Stem Cell & Ageing of the Academy of Medical Sciences at Zhengzhou University

Science events

NatureEvents Directory

QD2018 - International Conference on Quantum Dots

Biopharma Innovation Cup 2018

International Conference on Physics, Mathematics and Statistics（ICPMS 2018）

Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults

Black hole explosions?

Unconventional superconductivity in magic-angle graphene superlattices

In this Supplement

Sponsor:

Science jobs

NatureJobs.com

Science events

NatureEvents Directory

Most read